A Covid Testing Crisis, Again

President Trump was elected in 2024 on the promise that he would fix the economy. Now, a new poll from The New York Times/Siena reveals that the issue may be driving voters away.Nate Cohn, the chief political analyst at The Times, explains what the poll tells us.Guest: Nate Cohn, ...  Show more

For years, social media companies have relied on an impenetrable first amendment protection to shield them from legal claims that their products are dangerous to children.But now, a cluster of plaintiffs are trying a different tact.Cecilia Kang, who covers technology, explains wh ...  Show more

A great day for science, a bad day for Covid-19. As the first Pfizer vaccines are given to patients in the UK, the Oxford-AstraZeneca vaccine publishes its data. Adam and Fergus chat to virologist Dr Elisabetta Groppelli about how the rollout might go - and learn some Italian whi ...  Show more

The first in an unfolding miniseries - The Vaccine - tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen, taking an inside look at the vaccine industry, and learning from ...

The rate of vaccination in the U.S. continues to slow. Maddie Sofia talks with NPR health correspondent Allison Aubrey about that and what can be done to get more people vaccinated. Also, making sense of the CDC's latest mask guidance. Have questions about the latest coronavirus ...  Show more

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ...  Show more